Decay-accelerating factor modulates induction of T cell immunity

Journal of Experimental Medicine

Volumn 201, Issue 10, 2005, Pages 1523-1530

  Heeger, Peter S ^a,b   Lalli, Peter N ^a,b   Lin, Feng ^b   Valujskikh, Anna ^a   Liu, Jinbo ^b   Muqim, Nasima ^b   Xu, Yuanyuan ^c   Medof, M Edward ^b  

^a LERNER RESEARCH INSTITUTE   (United States)

^b CASE WESTERN RESERVE UNIVERSITY   (United States)

^c The University of Alabama at Birmingham   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANAPHYLATOXIN; CLASSICAL COMPLEMENT PATHWAY C3 C5 CONVERTASE; DECAY ACCELERATING FACTOR;

ANIMAL CELL; ANTIGEN PRESENTING CELL; ARTICLE; CELL FUNCTION; CELL INTERACTION; CELL PROLIFERATION; CELLULAR IMMUNITY; COMPLEMENT ACTIVATION; CONTROLLED STUDY; DAF1 GENE; EFFECTOR CELL; GENE; HOST CELL; IMMUNE RESPONSE; IMMUNOREACTIVITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RECEPTOR DOWN REGULATION; T LYMPHOCYTE ACTIVATION;

ANIMALS; ANTIGENS, CD55; CELL COMMUNICATION; CELL PROLIFERATION; COMPLEMENT C3-C5 CONVERTASES; COMPLEMENT SYSTEM PROTEINS; DENDRITIC CELLS; DOWN-REGULATION; ENZYME ACTIVATION; FEMALE; IMMUNITY, CELLULAR; INTERLEUKIN-6; LEUKEMIA INHIBITORY FACTOR; LYMPHOCYTE ACTIVATION; MALE; MICE; MICE, KNOCKOUT; SIGNAL TRANSDUCTION; T-LYMPHOCYTES;

EID: 19344364971     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.20041967     Document Type: Article

References (28)

1. Janeway, C., Jr., P. Travers, M. Walport, and M.J. Shlomchik. 2004. Innate immunity. In Immunobiology. Garland Publishing, New York. 37-100.
2. Suresh, M., H. Molina, M.S. Salvato, D. Mastellos, J.D. Lambris, and M. Sandor. 2003. Complement component 3 is required for optimal expansion of CD8 T cells during a systemic viral infection. J. Immunol. 170:788-794.
3. Pratt, J.R., S.A. Basheer, and S.H. Sacks. 2002. Local synthesis of complement component C3 regulates acute renal transplant rejection. Nat. Med. 8:582-587.
4. Nataf, S., S.L. Carroll, R.A. Wetsel, A.J. Szalai, and S.R. Barnum. 2000. Attenuation of experimental autoimmune demyelination in complement-deficient mice. J. Immunol. 165:5867-5873.
5. Kopf, M., B. Abel, A. Gallimore, M. Carroll, and M.F. Bachmann. 2002. Complement component C3 promotes T-cell priming and lung migration to control acute influenza virus infection. Nat. Med. 8:373-378.
6. Kaech, S.M., E.J. Wherry, and R. Ahmed. 2002. Effector and memory T-cell differentiation: implications for vaccine development. Nat. Rev. Immunol. 2:251-262.
7. Pien, G.C., K.B. Nguyen, L. Malmgaard, A.R. Satoskar, and C.A. Biron. 2002. A unique mechanism for innate cytokine promotion of T cell responses to viral infections. J. Immunol. 169:5827-5837.
8. Goldberg, J., P. Shrikant, and M.F. Mescher. 2003. In vivo augmentation of tumor-specific CTL responses by class I/peptide antigen complexes on microspheres (large multivalent immunogen). J. Immunol. 170:228-235.
9. Medof, M.E., T. Kinoshita, and V. Nussenzweig. 1984. Inhibition of complement activation on the surface of cells after incorporation of decay-accelerating factor (DAF) into their membranes. J. Exp. Med. 160:1558-1578.
10. Hamann, J., B. Vogel, G.M. van Schijndel, and R.A. van Lier. 1996. The seven-span transmembrane receptor CD97 has a cellular ligand (CD55, DAF). J. Exp. Med. 184:1185-1189.
11. Leemans, J.C., A.A. te Velde, S. Florquin, R.J. Bennink, K. de Bruin, R.A. van Lier, T. van der Poll, and J. Hamann. 2004. The epidermal growth factor-seven transmembrane (EGF-TM7) receptor CD97 is required for neutrophil migration and host defense. J. Immunol. 172:1125-1131.
12. Walter, E.I., W.D. Ratnoff, K.E. Long, J.W. Kazura, and M.E. Medof 1992. Effect of glycoinositolphospholipid anchor lipid groups on functional properties of decay-accelerating factor protein in cells. J. Biol. Chem. 267:1245-1252.
13. Medof, M.E., S. Nagarajan, and M.L. Tykocinski. 1996. Cell-surface engineering with GPI-anchored proteins. FASEB J. 10:574-586.
14. Cerny, J., H. Stockinger, and V. Horejsi. 1996. Noncovalent associations of T lymphocyte surface proteins. Eur. J. Immunol. 26:2335-2343.
15. Horejsi, V., K. Drbal, M. Cebecauer, J. Cerny, T. Brdicka, P. Angelisova, and H. Stockinger. 1999. GPI-microdomains: a role in signalling via immunoreceptors. Immunol. Today. 20:356-361.
16. Simpson, E., D. Scott, and P. Chandler. 1997. The male-specific histocompatibility antigen, H-Y: a history of transplantation, immune response genes, sex determination and expression cloning. Annu. Rev. Immunol. 15:39-61.
17. Davis, L.S., S.S. Patel, J.P. Atkinson, and P.E. Lipsky. 1988. Decay-accelerating factor functions as a signal transducing molecule for human T cells. J. Immunol. 141:2246-2252.
18. Buono, C., C.E. Come, J.L. Witztum, G.F. Maguire, P.W. Connelly, M. Carroll, and A.H. Lichtman. 2002. Influence of C3 deficiency on atherosclerosis. Circulation. 105:3025-3031.
19. Kim, A.H., I.D. Dimitriou, M.C. Holland, D. Mastellos, Y.M. Mueller, J.D. Altman, J.D. Lambris, and P.D. Katsikis. 2004. Complement c5a receptor is essential for the optimal generation of antiviral CD8+ T cell responses. J. Immunol. 173:2524-2529.
20. Arvieux, J., H. Yssel, and M.G. Colomb. 1988. Antigen-bound C3b and C4b enhance antigen-presenting cell function in activation of human T-cell clones. Immunology. 65:229-235.
21. Kerekes, K., J. Prechl, Z. Bajtay, M. Jozsi, and A. Erdei. 1998. A further link between innate and adaptive immunity: C3 deposition on antigen-presenting cells enhances the proliferation of antigen-specific T cells. Int. Immunol. 10:1923-1930.
22. Kerekes, K., P.D. Cooper, J. Prechl, M. Jozsi, Z. Bajtay, and A. Erdei. 2001. Adjuvant effect of gamma-inulin is mediated by C3 fragments deposited on antigen-presenting cells. J. Leukoc. Biol. 69:69-74.
23. Kawamoto, S., A. Yalcindag, D. Laouini, S. Brodeur, P. Bryce, B. Lu, A.A. Humbles, H. Oettgen, C. Gerard, and R.S. Geha. 2004. The anaphylatoxin C3a down regulates the Th2 response to epicutaneously introduced antigen. J. Clin. Invest. 114:399-407.
24. Teague, T.K., D. Hildeman, R.M. Kedl, T. Mitchell, W. Rees, B.C. Schaefer, J. Bender, J. Kappler, and P. Marrack. 1999. Activation changes the spectrum but not the diversity of genes expressed by T cells. Proc. Natl. Acad. Sci. USA. 96:12691-12696.
25. Lin, F., Y. Fukuoka, A. Spicer, R. Ohta, N. Okada, C.L. Harris, S.N. Emancipator, and M. E. Medof. 2001. Tissue distribution of products of the mouse decay-accelerating factor (DAF) genes. Exploitation of a Daf1 knock-out mouse and site-specific monoclonal antibodies. Immunology. 104:215-225.
26. Lantz, O., I. Grandjean, P. Matzinger, and J.P. Di Santo. 2000. Gamma chain required for naive CD4+ T cell survival but not for antigen proliferation. Nat. Immunol. 1:54-58.
27. He, C., and P.S. Heeger. 2004. CD8 T cells can reject major histocompatibility complex class I-deficient skin allografts. Am. J. Transplant. 4:698-704.
28. He, C., S. Schenk, Q. Zhang, A. Valujskikh, J. Bayer, R.L. Fairchild, and P.S. Heeger. 2004. Effects of T cell frequency and graft size on transplant outcome in mice. J. Immunol. 172:240-247.